Title : Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM\/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis - Martin_2015_Oncologist_20_111
Title : A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome - Caronia_2011_Clin.Cancer.Res_17_2006